Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsSymptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV statusXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistanceScreening strategies for active tuberculosis: focus on cost-effectivenessDevelopment, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?Diagnostics for pulmonary tuberculosisImpact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesEuropean union standards for tuberculosis careHIV and tuberculosis--science and implementation to turn the tide and reduce deathsTranslating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisEvaluation of respiratory diseaseSignificant roadblocks exist in developing sputum sample libraries for clinical validation of novel in vitro diagnosticsPoint-of-care assays for tuberculosis: role of nanotechnology/microfluidics.Point-of-care diagnosis of tuberculosis: past, present and futurePoint-of-care testing in India: missed opportunities to realize the true potential of point-of-care testing programs.Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.Clinical research and development of tuberculosis diagnostics: moving from silos to synergyBioterrorism and the Role of the Clinical Microbiology LaboratoryInfection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the KeyImpact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaSelf-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatmentRapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyScreening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyDetection of Mycobacterium tuberculosis in sputum by gas chromatography-mass spectrometry of methyl mycocerosates released by thermochemolysisDrug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South AfricaThe impact and cost of scaling up GeneXpert MTB/RIF in South AfricaAltered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory SyndromePopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationThe impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort studySystematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosisField evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in TanzaniaCost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in ChinaMulti drug resistant tuberculosis in Mosango, a rural area in the Democratic Republic of CongoCorrelation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility resultsThe importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission modelImpact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trialThe burden of MDR/XDR tuberculosis in coastal plains population of China
P2860
Q22241307-285B64A4-519A-4AE7-A51E-C42FBA142D9AQ24200879-AAF84195-0EE1-4731-8D0C-16E1ED638EEEQ24201293-C19532CF-6554-4486-A689-29D77919211EQ24201466-48E74161-2902-42C9-A2F8-A80EA453A96EQ24203927-6D269842-93AD-46C7-B69A-13FB8DF2D8EDQ26740226-850DF70F-F119-40F0-9EC8-0EB36D629F09Q26740240-4B0127F7-A2F2-4A99-A953-347EEBA1E362Q26752633-7D821CD6-E4EF-4B6C-AA35-F149E0F5E894Q26767271-588B44D2-1014-41F9-AE4B-96C52BEB9D8AQ26823223-D536534A-572B-4C62-ABA6-AD59196E0A61Q26824501-D830CC39-5881-4D6F-9152-F3303E148D5FQ26824812-1EC18811-02A1-426B-A0A9-ECC5F8C5E15EQ26828791-F8999E95-EC55-4AB6-A8A5-0F2F1BC38739Q26866442-E50DCF87-316C-46EF-A286-7D9F072D66D4Q27004505-BD6C2182-8BE0-4986-989E-EB2D1547C421Q27004667-6BF6B452-DB94-4F52-BCEA-EA6001FE116DQ27307027-4E52EE44-7F2C-43DC-8850-5DF4CE5D4CF2Q27690864-CEB09A0F-3536-4519-AC5A-1A359405379CQ28383710-8BB95753-FC8C-48D6-A35C-453FD57A523CQ28388247-5DBE62A0-599B-44FB-A8BE-ABF616468339Q28393098-C4ED154A-17DF-44AB-A9EF-D098486452FBQ28394564-94C49610-5487-420A-9F70-FE7338262448Q28477499-19331ED1-B3EF-4D65-BBB6-2411B6D5057EQ28477855-25461DEC-5673-48B0-AA13-30110732AEBFQ28479276-70D04553-84CB-47C3-B5EA-BCB4F539554EQ28479309-E9A74220-4FCF-4ADE-B746-D77D214AED22Q28481398-9C23EE03-E343-47DB-B17B-E7DDD67A0280Q28482343-69F16761-231D-480C-B75D-D16AAA2075E7Q28484044-B503551B-A20D-47DB-8EE3-10D76DEE3F9CQ28484347-08A237FC-8AEE-4FEC-94BF-D761F965C67BQ28485280-BBE58B75-1A0D-4C66-A12C-3945BE8648D8Q28485439-7182B0FE-A403-43F3-90B4-093A74DA788AQ28534025-595BDD2F-C531-40DA-AB6A-1E47FD1F0944Q28534535-1822EE91-873E-4637-99B9-0A0BC967F679Q28534773-65B2B031-B2E3-4C7C-918D-8120AFA711AFQ28537853-C5055B04-2B55-4FC7-BF5F-AEEEE15DFC6FQ28540488-1E1297AF-3CF5-41C5-A21B-22ACC1215046Q28540733-9AD5393B-8194-49EE-90A7-90421AB48974Q28542588-E16A2F23-DE32-4CD5-B8B4-07FBB8870B2AQ28543426-333DC298-D620-40EC-88BC-23A1ABC48E80
P2860
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Feasibility, diagnostic accura ...... lticentre implementation study
@ast
Feasibility, diagnostic accura ...... lticentre implementation study
@en
type
label
Feasibility, diagnostic accura ...... lticentre implementation study
@ast
Feasibility, diagnostic accura ...... lticentre implementation study
@en
prefLabel
Feasibility, diagnostic accura ...... lticentre implementation study
@ast
Feasibility, diagnostic accura ...... lticentre implementation study
@en
P2093
P2860
P921
P3181
P1433
P1476
Feasibility, diagnostic accura ...... lticentre implementation study
@en
P2093
Andrew Whitelaw
Catharina C Boehme
Christen Gray
David Alland
Eduardo Gotuzzo
Frank Cobelens
Heather Alexander
Heidi Albert
Joy S Michael
Kalaiselvan Sagadevan
P2860
P304
P3181
P356
10.1016/S0140-6736(11)60438-8
P407
P577
2011-04-18T00:00:00Z